22 December 2014, 9:10 am
A combination of entecavir plus tenofovir effectively suppressed hepatitis B virus (HBV) in people with resistance to other antivirals, according to results from the European ENTEBE study presented at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting last month in Boston. Another study, however, showed that for some resistant patients, tenofovir


19 December 2014, 9:20 am
A paper this month in the Journal of Acquired Immune Deficiency Syndromes finally makes publicly available a study - originally reported by Aidsmap nearly two years ago from the 2013 CROI conference but until now unobtainable even as an abstract – which gives an estimate for the effectiveness of 100% condom use as the


19 December 2014, 9:00 am
There is a high mortality rate among people living with HIV undergoing treatment for tuberculosis (TB), according to the results of a meta-analysis published in PLOS One. The mortality rate ranged between 8 and 14% but the risk of death was significantly lower for people who received antiretroviral treatment (ART) during their TB therapy. “This


18 December 2014, 8:30 am
An estimated 813,000 people with diagnosed hepatitis C in the US have undergone liver disease staging and meet the 'highest' or 'high' priority criteria for immediate treatment, according to an analysis presented at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting last month in Boston. The number would be even


18 December 2014, 7:10 am
Nearly one-third of chronic hepatitis C patients with liver cirrhosis and 12% with advanced fibrosis progressed to decompensation within five years, and 23% and 11%, respectively, died, according to a study presented at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting last month in Boston. These findings underscore the urgent need for


1 2
LATEST VIDEOS

TAKE ACTION
UPCOMING EVENTS
    • No upcoming events
  • YOUR NEWS
  • View All Add your news
    YOUR PICTURES
  • LATEST TWEETS